Crexont Patient Assistance Program
Don’t let the high cost of brand extended-release carbidopa-levodopa disrupt your Parkinson’s disease treatment. We help eligible patients access Crexont (carbidopa/levodopa extended-release capsules) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Crexont (carbidopa/levodopa extended-release capsules) is FDA-approved for treatment of Parkinson's disease. A novel formulation combining immediate-release and extended-release beads to smooth out levodopa pharmacokinetics — reducing 'off' time and motor fluctuations compared with immediate-release carbidopa/levodopa.
- Without assistance, Crexont costs commonly run approximately $1,200–$1,800 per month.
- Through AffordMyPrescriptions, qualifying patients can access Crexont for a flat $69.95 per month.
- Other carbidopa/levodopa formulations: immediate-release generic (Sinemet — very cheap, ubiquitous first-line), sustained-release Sinemet CR (generic), Rytary (older brand ER — now generic), Duopa (intestinal gel infusion for advanced disease), Inbrija (inhaled levodopa for off episodes), Dhivy (chewable). Other Parkinson's drugs: dopamine agonists (pramipexole, ropinirole, rotigotine patch; apomorphine), MAO-B inhibitors (rasagiline, selegiline — generic; safinamide/Xadago), COMT inhibitors (entacapone, opicapone/Ongentys, tolcapone), amantadine ER (Gocovri, Osmolex for dyskinesia). Movement disorder specialist for advanced disease.
What is Crexont Prescription Assistance Program?
The Crexont Patient Assistance Program helps eligible patients access Crexont for Parkinson’s disease at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Crexont PAP enrollment for a flat $69.95 per month — so you never face a gap in Crexont therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Crexont enrollment — so you never face a gap in your Parkinson’s disease treatment.
Pharmacy Price Comparison
- Without assistance, Crexont costs thousands of dollars per month. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic Rytary (alt ER) | ~$150/mo | Generic ER carbidopa/levodopa |
| Walgreens | ~$1,700/mo | Save substantially |
| CVS Pharmacy | ~$1,800/mo | Save substantially |
| Walmart | ~$1,300/mo | Save substantially |
| Specialty pharmacy | ~$1,200/mo | Save substantially |
| Generic carbidopa/levodopa IR | ~$10/mo | Cheap generic Sinemet alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Crexont — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Crexont Prescription Program?
The Crexont Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Generic Sinemet is very cheap and standard first-line. Generic Rytary (older ER formulation) is now available. Crexont provides refined pharmacokinetics for patients with problematic motor fluctuations.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Crexont assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Crexont is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Crexont:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $1,200–$1,800 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Crexont assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Crexont Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Crexont:
Crexont uses proprietary technology combining immediate-release and multiple extended-release levodopa beads to produce steadier plasma levodopa levels — reducing ‘off’ periods and dyskinesia compared with immediate-release. A refined delivery for patients experiencing motor fluctuations.
How It Works:
Parkinson’s disease is caused by loss of dopamine-producing neurons in the substantia nigra — depleted dopamine causes motor symptoms (tremor, rigidity, bradykinesia, postural instability). Levodopa is the amino acid precursor of dopamine — it crosses the blood-brain barrier and is converted to dopamine in remaining neurons. Standard therapy but plagued by a short half-life causing ‘wearing off’ episodes and dose-related dyskinesias in advanced disease. Crexont combines immediate-release beads (rapid onset) with multiple extended-release bead populations (sustained delivery) — producing plasma levodopa levels quicker to peak than Sinemet CR and more sustained than immediate-release Sinemet. Carbidopa (a peripheral dopa-decarboxylase inhibitor) reduces peripheral levodopa breakdown, allowing a lower levodopa dose and reducing peripheral side effects.
Form and Use:
Crexont extended-release capsules. Multiple strengths. Dosing is individualized based on response and prior levodopa exposure. Movement disorder specialist or neurologist prescribing is recommended.
Generic Availability:
No generic Crexont. Other carbidopa/levodopa formulations: immediate-release generic Sinemet (very cheap, ubiquitous first-line), Sinemet CR generic (sustained-release), Rytary (older brand ER carbidopa/levodopa — now generic), Duopa (intestinal gel infusion for advanced disease), Inbrija (inhaled levodopa for on-demand off episodes — brand), Dhivy (chewable formulation). Adjuncts for motor fluctuations: MAO-B inhibitors, COMT inhibitors, dopamine agonists, amantadine ER (Gocovri, Osmolex — for dyskinesia). Deep brain stimulation for advanced disease. Movement disorder specialist consultation for optimization.
Warnings:
Hallucinations, psychosis, impulse control disorders (increased dopaminergic tone — gambling, shopping, hypersexuality), sudden sleep episodes (can occur without warning — caution driving), orthostatic hypotension, dyskinesia (long-term levodopa side effect), embryo-fetal considerations, do not stop abruptly (neuroleptic malignant syndrome-like reaction), motor fluctuations progressing over years of levodopa therapy. Other: nausea, vomiting, dizziness, confusion (especially elderly), somnolence. Drug interactions with MAO inhibitors (avoid non-selective) and certain antipsychotics (dopamine blockers). Neurologist follow-up essential.
FAQ (Frequently Asked Questions)
How much does Crexont cost without insurance?
$1,200–$1,800 per month at retail pharmacies. Generic immediate-release Sinemet (carbidopa/levodopa) costs $5–$20 per month with GoodRx — a vastly cheaper standard formulation.
How is Crexont different from generic Sinemet?
Generic Sinemet (immediate-release carbidopa/levodopa) is first-line — its short half-life causes ‘wearing off’ between doses (motor fluctuations) in advanced Parkinson’s. Crexont combines immediate-release and extended-release beads for steadier plasma levodopa — reducing ‘off’ time and dose-related dyskinesias. The advantage grows as disease progresses.
How is Crexont different from generic Rytary?
Both are ER carbidopa/levodopa. Rytary was the first ER capsule formulation (now generic). Crexont is a refined formulation with a different bead combination — designed to produce even smoother levodopa levels with quicker onset. Choice by prescriber preference and patient response.
Do I still take other Parkinson's medications with Crexont?
Often yes — Parkinson’s therapy is individualized. Adjuncts include MAO-B inhibitors (rasagiline, selegiline generic; safinamide brand), COMT inhibitors (entacapone generic; opicapone brand), dopamine agonists (pramipexole, ropinirole, rotigotine patch), amantadine ER (for dyskinesia), and on-demand rescue (Inbrija, apomorphine). A movement disorder specialist optimizes the regimen.
What are common Crexont side effects?
Nausea, vomiting, dyskinesia, dizziness, orthostatic hypotension, confusion (especially elderly), hallucinations. Serious: impulse control disorders (compulsive gambling, shopping, sexual behavior — screen for), sudden sleep episodes, and a neuroleptic malignant syndrome-like reaction if stopped abruptly.
Take Control of Your Medication Costs
Reducing motor fluctuations transforms quality of life in Parkinson’s. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.